Day: March 4, 2021

 Aðalfundur Regins hf. verður haldinn miðvikudaginn 10. mars 2021 kl. 16:00 í Hvammi fundarsal á Grand Hótel Reykjavík, Sigtúni 28, 105 Reykjavík.Framboðsfrestur til stjórnar Regins hf. rann út þann 3. mars sl.Eftirtaldir einstaklingar hafa gefið kost á sér til setu í stjórn félagsins: Í framboði til stjórnar eru:Albert Þór JónssonBryndís HrafnkelsdóttirGuðrún Tinna ÓlafsdóttirHeiðrún Emilía JónsdóttirMár Wolfgang MixaTómas Kristjánsson Mat stjórnar er að öll framboð séu gild sbr. 63.gr.a. hlutafélagalaga nr. 2/1995.Nánari upplýsingar um frambjóðendur má finna í viðhengi.Engar breytingar hafa orðið á dagskrá og tillögum sem birtar voru 16. febrúar sl. Önnur fundargögn tengd aðalfundi, umboðsform, skýrsla tilnefningarnefndar o.fl. má nálgast á vef félagsins www.reginn.is/fjarfestavefur. Kópavogur, 4. mars 2021.Stjórn Regins hf.  ViðhengiReginn...

HAUPPAUGE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) — Orbit International Corp. (OTC PINK:ORBT), an electronics manufacturer and software solution provider, today announced that its Electronics Group (“OEG”), reported bookings for the month of February 2021 in excess of $1,250,000. Deliveries for certain of these orders have already commenced and are expected to continue through the second quarter of 2023.Mitchell Binder, President and CEO of Orbit International commented, “The orders received during the month were highlighted by the commencement of a new production award of a second-generation unit used on major aircraft programs as well as a follow-on order for a display also used on a major aircraft program. We are encouraged that this new generation unit could provide our Company with significant future business as it has the potential...

Englewood Cliffs NJ, March 04, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTC QB: SILO), a developmental stage biopharmaceutical company, today announced that it has executed an exclusive option agreement with the University of Maryland, Baltimore to explore a novel invention generally known as “Joint-homing peptides for use in the investigation and treatment of arthritogenic processes.”The ability of the peptides to target inflamed endothelium suggests they could be used to target drug delivery to the diseased joints. This approach could enhance the therapeutic effect of current and future therapies and decrease potential systemic toxicity despite systemic administration of the drug. These peptides have the potential for the development of fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis. The peptides...

TORONTO, March 04, 2021 (GLOBE NEWSWIRE) — Harvest Portfolios Group Inc. (“Harvest”) is pleased to announce that Big Pharma Split Corp. (the “Company”) has completed the overnight offering of Preferred Shares and Class A Shares of the Company. Total gross proceeds of the offering were $9.3 million, bringing the Company’s net assets to approximately $30.5 million.The shares will trade on the Toronto Stock Exchange under the existing symbols of PRM.PR.A (Preferred Shares) and PRM (Class A Shares).The Preferred Shares were offered at a price of $10.50 per Preferred Share to yield 4.8% and the Class A Shares were offered at a price of $13.75 per Class A Share to yield 9.0%.The offering was co-led by BMO Capital Markets, CIBC World Markets Inc. and Scotia Capital Inc., and also included National Bank Financial Inc., TD Securities Inc.,...

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./TORONTO, March 04, 2021 (GLOBE NEWSWIRE) — GameSquare Esports Inc. (CSE: GSQ) (FRA: 29Q1) (“GameSquare” or the “Company”), an international esports company, is pleased to announce that it has closed its previously announced upsized “bought deal” private placement of an aggregate of 16,700,000 subscription receipts of the Company (the “Subscription Receipts”) at a price of C$0.42 per Subscription Receipt (the “Issue Price”) for aggregate gross proceeds to the Company of C$7,014,000 (the “Offering”). The Offering was underwritten by a syndicate led by Canaccord Genuity Corp. (“Canaccord”) and including Echelon Wealth Partners Inc. and Eight Capital (collectively, the “Underwriters”). In addition to the...

NETANYA, Israel, March 04, 2021 (GLOBE NEWSWIRE) — RADA Electronic Industries Ltd. (“RADA”) (NASDAQ and TASE: RADA), a global defense technology company, today announced the pricing of its public offering of 4,500,000 ordinary shares at a public offering price of $11.50 per share. The gross proceeds to RADA from this offering are expected to be approximately $51.75 million before deducting the underwriting discounts and commissions and other offering expenses payable by RADA.RADA has granted the underwriters a 30-day option to purchase up to an additional 675,000 ordinary shares on the same terms and conditions.  The offering is expected to close on or about March 8, 2021, subject to customary closing conditions.RADA intends to use the net proceeds from this offering for general corporate purposes.Jefferies LLC, Baird and Canaccord...

*Board Declares Cash Dividend* MIND CTI to Host Annual Meeting of ShareholdersYOQNEAM, Israel, March 04, 2021 (GLOBE NEWSWIRE) — MIND C.T.I. LTD. – (NasdaqGM: MNDO), a leading provider of convergent end-to-end prepaid/postpaid billing and customer care product based solutions for service providers, unified communications analytics and call accounting solutions for enterprises as well as enterprise messaging solutions, today announced results for its fourth quarter and full year ended December 31, 2020.The following will summarize our business in the fourth quarter of 2020 and provide a more detailed review of the financial results for the quarter and for the full year. Full financial results can be found in the Company News section of our website at http://www.mindcti.com/company/news/ and in our Form 6-K.Financial Highlights of...

WEST LAFAYETTE, Ind., March 04, 2021 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that Robert Leasure, Jr., President and Chief Executive Officer, and Beth Taylor, Vice President of Finance and Chief Financial Officer, are scheduled to participate in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021. Management will be available for one-on-one meetings throughout both days. A webcast of the presentation will be available on March 9, 2021, at 7:00 a.m. ET through a link that will be posted on the Investors section of the Company’s website at ir.inotivco.com and will be available for approximately 90 days.About the CompanyBioanalytical...

TORONTO, March 04, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that one of its lead scientists, Dr. Daniel Hassett, Professor at the University of Cincinnati College of Medicine, published a paper entitled “AB569, A Non-toxic Combination of Acidified Nitrite and EDTA, is Effective at Killing the Notorious Iraq/Afghanistan Combat Wound Pathogens, Multi-Drug Resistant Acinetobacter baumannii and Acinetobacter spp.” in the journal PloS One. Dr. Hassett invented AB569 at the University of Cincinnati College of Medicine.Dr. Hassett, who collaborated with both the United States Air Force and Arch, demonstrated that AB569 kills multi-drug resistant strains of Acinetobacter baumannii and Acinetobacter spp. bacteria. These pathogens have been shown to infect...